1. Home
  2. RPGL vs HCWB Comparison

RPGL vs HCWB Comparison

Compare RPGL & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$0.44

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$0.41

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPGL
HCWB
Founded
2015
2018
Country
Singapore
United States
Employees
8
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
2.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RPGL
HCWB
Price
$0.44
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
1.3M
619.4K
Earning Date
05-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.25
52 Week High
$8.44
$17.80

Technical Indicators

Market Signals
Indicator
RPGL
HCWB
Relative Strength Index (RSI) 42.79 45.40
Support Level $0.39 $0.25
Resistance Level $0.64 $0.78
Average True Range (ATR) 0.10 0.04
MACD 0.02 0.03
Stochastic Oscillator 27.68 81.30

Price Performance

Historical Comparison
RPGL
HCWB

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: